Reviewer Board (7)

Members of the reviewer board are selected from all IJNS reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.

Dr. Yvonne A. Daniel
Haematological Sciences, Viapath at Guy's & St Thomas' NHS Foundation Trust, London SE1 7EH, UK; Public Health England, NHS Sickle Cell and Thalassemia Screening Programme, London SE16LH, UK
Interests: all aspects of screening and diagnosis of haemoglobinopathies
Dr. Marleen Jansen
Centre for Health Protection, National Institute for Public Health and the Environment, NL-3720 BA Bilthoven, The Netherlands
Interests: different approaches internationally to start, expand and improve neonatal screening programs
Dr. Denise M. Kay
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA
Interests: Genetic diseases affecting infants and children; newborn screening; genetic epidemiology; Expanded genetic analysis and next-generation sequencing in newborn screening; cystic fibrosis (cf); Spinal Muscular Atrophy (SMA); Genetics of congenital malformations
Dr. Yana Sandlers
Department of Chemistry, Cleveland State University, Cleveland, OH 44115, USA
Interests: clinical chemistry; mass spectrometry; high throughput; amino acids; acylcarnitines; organic acids
Dr. Silvia Tortorelli
Biochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Interests: inborn errors of metabolism, peroxisomal and lysosomal disorders; reduction of false positive with second tier tests or novel biomarkers
Dr. Samantha A. Vergano
Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Norfolk, VA 23507, USA
Interests: hyperammonemia in neonates; lysosomal storage diseases on NBS; psychosocial impact of positive/false positive screenings on caregivers
Professor Seiji Yamaguchi
Department of Pediatrics, Shimane University School of Medicine, 89-1 En-ya-cho, Izumo Shimane, 693-8501 Japan
Interests: screening for organic acidemias and fatty acid oxidation defects; expanded newborn screening; new treatment option of bezafibrate for fatty acid; molecular study on fatty acid oxidation defects oxidation defects
Back to TopTop